Send me a link:

*Text messaging rates may apply.

 Dow Up 0.12% Nasdaq Up 0.26%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
13.53 Up 0.44(3.36%) 12:24PM EDT - Nasdaq Real Time Price
Prev Close:13.09
Open:13.14
Bid:13.49 x 200
Ask:13.51 x 600
1y Target Est:36.29
Beta:3.17
Next Earnings Date: 6-Aug-14CLDX Earnings announcement
Day's Range:12.92 - 13.63
52wk Range:10.76 - 38.84
Volume:679,157
Avg Vol (3m):2,492,570
Market Cap:1.21B
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXUp 3.36%1.21B
DNDNDown 1.39%319.68M
LLYDown 0.46%67.92B
RHHBYDown 0.33%249.03B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):553.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Jun-14) :-0.32
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback